EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation

Marta Ribeiro, Joanna Jager, Marta Furtado, Teresa Carvalho, Joaquim M S Cabral, Dulce Brito, Maria Carmo-Fonseca, Sandra Martins, Simão Teixeira da Rocha

Human Cell · 2024

DOI: 10.1007/s13577-024-01073-y ↗

Kurz gefasst

Fallbericht in der Zeitschrift Human Cell, 2024. Verfasst von Marta Ribeiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Port…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Cardiomyopathy, Hypertrophic, Carrier Proteins, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LaCaixa Foundation, Universidade de Lisboa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is frequently caused by mutations in the MYPBC3 gene, which encodes the cardiac myosin-binding protein C (cMyBP-C). Most pathogenic variants in MYPBC3 are either nonsense mutations or result in frameshifts, suggesting that the primary disease mechanism involves reduced functional cMyBP-C protein levels within sarcomeres. However, a subset of MYPBC3 variants are missense mutations, and the molecular mechanisms underlying their pathogenicity remain elusive. Upon in vitro differentiation into cardiomyocytes, induced pluripotent stem cells (iPSCs) derived from HCM patients represent a valuable resource for disease modeling. In this study, we generated two iPSC lines from peripheral blood mononuclear cells (PBMCs) of a female with early onset and severe HCM linked to the MYBPC3 : c.772G > A variant. Although this variant was initially classified as a missense mutation, recent studies indicate that it interferes with splicing and results in a frameshift. The generated iPSC lines exhibit a normal karyotype and display hallmark characteristics of pluripotency, including the ability to undergo trilineage differentiation. These novel iPSCs expand the existing repertoire of MYPBC3 -mutated cell lines, broadening the spectrum of resources for exploring how diverse mutations induce HCM. They additionally offer a platform to study potential secondary genetic elements contributing to the pronounced disease severity observed in this individual.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsCardiomyopathy, HypertrophicCarrier ProteinsCell DifferentiationHumansFemaleMyocytes, CardiacMutation, MissenseSeverity of Illness IndexMutationCell LineFrameshift MutationLeukocytes, MononuclearCells, CulturedMyosin Binding Protein C

Stichwörter der Autor:innen

MYBPC3Disease modelingHypertrophic cardiomyopathyhiPSCs

Substanzen

Carrier ProteinsMyosin Binding Protein C

Autor:innen und Institutionen

  • iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
  • Associate Laboratory i4HB Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
  • Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
  • Faculdade de Medicina, Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisbon, Portugal.
  • Heart and Vessels Department, Cardiology Division, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.
  • Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

Förderung

  • LaCaixa Foundation
  • Universidade de Lisboa

Zitieren

APA

Ribeiro, M., Jager, J., Furtado, M., Carvalho, T., Cabral, J. M. S., Brito, D., Carmo-Fonseca, M., Martins, S., & da Rocha, S. T. (2024). Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation. Human Cell. https://doi.org/10.1007/s13577-024-01073-y

Vancouver

Ribeiro M, Jager J, Furtado M, Carvalho T, Cabral JMS, Brito D, et al. Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation. Human Cell. 2024. doi:10.1007/s13577-024-01073-y

BibTeX
@article{Ribeiro2024,
  author = {Ribeiro, Marta and Jager, Joanna and Furtado, Marta and Carvalho, Teresa and Cabral, Joaquim M S and Brito, Dulce and Carmo-Fonseca, Maria and Martins, Sandra and da Rocha, Simão Teixeira},
  title = {Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01073-y}
}
Kostenlos starten →